Navigation Links
Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results
Date:3/5/2008

projections and the factors influencing them will likely change, we will not necessarily update the information. Such information speaks only as of the date of this release.

This announcement contains translations of certain Renminbi amounts into US dollars at specified rates solely for the convenience of readers. Unless otherwise noted, all translations from Renminbi to US dollars as of and for the quarter ended December 31, 2007 were made at the noon buying rate in the City of New York for cable transfers in Renminbi per US dollar as certified for customs purposes by the Federal Reserve Bank of New York, or the noon buying rate, as of December 31, 2007, which was RMB7.2946 to US$1.00. Mindray makes no representation that the Renminbi or US dollar amounts referred to in this release could have been or could be converted into US dollars or Renminbi, as the case may be, at any particular rate or at all.

All references to "shares" are to our ordinary shares, which are divided into two classes, Class A and Class B. Each of our American Depositary Shares, which trade on the New York Stock Exchange, represents one Class A ordinary share.

The accounting policies underlying the financial information for the segmental reporting are based primarily on statutory accounting requirements in the PRC.

Exhibit 1

MINDRAY MEDICAL INTERNATIONAL LIMITED

CONDENSED CONSOLIDATED BALANCE SHEETS

As at December 31, As at December 31,

2006 2007

RMB RMB US$

(derived from

audited

financials) (unaudited)(unaudited)

ASSETS (In thousands) (In thousands)

Current assets:


'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Mindray to Report Fourth Quarter and Fiscal Year 2007 Financial Results on March 5, 2008
2. Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting
3. Mindray to Attend 2008 CLSA Asia Investors Forum
4. Mindray to Attend 2007 RSNA Conference in Chicago
5. Mindray to Report Third Quarter 2007 Financial Results on November 1, 2007
6. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
7. Physicians Wellness Network and Home Access Health to Provide Medically Compliant Diabetes Testing Sold Directly to Consumers
8. Medical Mutual of Ohio Issues Fraud Report
9. Dental Network of America Inc. Launches Integrated Medical-Dental Health Program
10. Template-Free Electronic Medical Record Wins AAFP User Satisfaction Survey.
11. Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... Dubai (PRWEB) May 19, 2013 Illuminations is ... therapist Trisha Caetano. Seminars will take place over the ... 6, Friday, June 7, and Saturday, June 8, 2013. , ... of symptoms, but focuses on the attitudes, patterns and coping ... the symptoms. Participants will learn to live a more integrated ...
(Date:5/18/2013)... FL (May 18, 2013) The use of ... a colonoscopy, according to new research presented today ... which begins days in advance of the procedure, ... medication to be taken at strict intervals. The ... doctors to see cancer and precancerous polyps in ...
(Date:5/18/2013)... 2013) A ground-breaking advance in colonoscopy technology ... research presented today at Digestive Disease Week (DDW). ... time for colonoscopies and exploring safer methods for ... use a device called a colonoscope to examine ... allows a doctor to look for precancerous polyps ...
(Date:5/18/2013)... The “World Healthcare IT Market: Trends & Forecast ... drivers, restraints, and opportunities in North America, Europe, Asia, ... 89 market data tables , ... Market" , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html , Early ... global healthcare IT market is expected to grow from ...
(Date:5/18/2013)... KY (PRWEB) May 18, 2013 During ... hearing loss should consider the legal protections they have, ... when problems arise with their child’s treatment or hearing ... , Since 1927, the American Speech-Language-Hearing Association has used ... disorders and to promote treatment, such as cochlear implants, ...
Breaking Medicine News(10 mins):Health News:Illuminations Brings World Renowned Therapist to the Middle East 2Health News:New smartphone application improves colonoscopy preparation 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3
... pathways involved in cancer metastasis , , MONDAY, March 3 ... development of human embryonic stem cells can inhibit the ... cancers, says a study by researchers at Northwestern University ... online issue of the Proceedings of the National ...
... of,health care improved by an average 2.3 percent a ... important advances but points to an overall,slowing in quality ... for Healthcare Research and Quality., The improvement rate, ... Healthcare Disparities Report, is lower than,the 3.1 percent average ...
... that governs development of human embryonic stem cells (hESCs) ... the deadliest skin cancer, Northwestern University researchers have discovered. ... pigment cells or melanocytes, has a death rate of ... less than 7.5 months. , The Northwestern scientists, ...
... Mich. Researchers have long searched for a novel ... tumor cells. But finding a drug that kills the ... researchers. , Now, researchers at the University of ... that is highly effective in cell cultures at inhibiting ...
... 3 Shopko has some groundbreaking,news for Council Bluffs. The ... well as a fifth store to the suburban Omaha market. ... This month, Shopko will open the first new store to ... departure from the look and layout of,current Shopko stores. The ...
... Adds Another 450 Southern California Healthcare Employees, ... (USW) today said that over 450 service workers ... have voted in a secret ballot,election overseen by ... the,union, uniting them with about 160 technical workers ...
Cached Medicine News:Health News:Embryonic Stem Cell Protein Inhibits Melanoma 2Health News:Modest Health Care Quality Gains Outpaced by Spending 2Health News:Modest Health Care Quality Gains Outpaced by Spending 3Health News:Protein in embryonic stem cells control malignant tumor cells 2Health News:Protein in embryonic stem cells control malignant tumor cells 3Health News:U-M researchers ID promising new cancer drug 2Health News:Shopko Announces New Prototype Store in Council Bluffs 2Health News:Apple Valley SMMC Workers Choose USW 2
(Date:5/17/2013)... PARIS , May 17, 2013  Sanofi (EURONEXT: ... the pivotal study, JAKARTA , examining ... its primary endpoint in both dose groups. The primary ... of spleen volume. Consistent with data reported in previous ... nausea and vomiting. Full results will be presented at ...
(Date:5/16/2013)... SINGAPORE and ZURICH , May ... Agency for Science, Technology and Research (A*STAR) and ... the first healthy volunteer has been dosed in a Phase ... on Cytos, proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In ... of this novel vaccine candidate and its potential to protect ...
(Date:5/16/2013)... -- Today, the National Patient Advocate Foundation acknowledges that the ... recently approved a bill that would prohibit insurers who ... fees for newer, more expensive oral anti-cancer drugs than ... side-effects. However, the bill was amended to include a ... be a barrier to patients with cancer and in ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... 7, 2011 The U.S. Food and Drug Administration ... treat patients with late-stage (metastatic) head and neck cancer. ... Combined with chemotherapy, Erbitux extended the lives of ... chemotherapy alone. Erbitux already is FDA-approved for certain types ...
... Psychemedics Corporation, hair testing for drugs of ... announced today that its laboratory has received international ... of laboratory testing including drugs of abuse ... The International Organization for Standardization/International Electrotechnical Commission ...
Cached Medicine Technology:FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer 2FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer 3Psychemedics Awarded ISO/IEC 17025 International Accreditation 2Psychemedics Awarded ISO/IEC 17025 International Accreditation 3
... into testing wells and read results. ... multiple drug screen cassette that can ... adulterants. It can test from one ... can be accompanied with four (4) ...
... Glucose Monitoring System is a patient insertable short-term ... the DexCom STS Receiver., The DexCom STS Sensor ... the DexCom STS Applicator by the user or ... held in place by an adhesive to the ...
... performing routine Holter,monitoring, the Burdick ... provides a,practical, no-nonsense diagnostic tool ... care,environment. This highly accurate and,easy-to-use ... variety,of configurations at a price ...
... PC-based ECG diagnostics complements transition to ... the incorporation of computer-based technology into ... diagnostic instrumentation have developed. Burdick's Universal ... EMRs making it the ideal choice ...
Medicine Products: